Alfuzosin hydrochloride is used to treat high blood pressure and treat certain functional symptoms of benign prostatic hyperplasia.
The global Alfuzosin Hydrochloride Sustained Release Tablets market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The “Alfuzosin Hydrochloride Sustained Release Tablets Industry Forecast” looks at past sales and reviews total world Alfuzosin Hydrochloride Sustained Release Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Alfuzosin Hydrochloride Sustained Release Tablets sales for 2024 through 2030. With Alfuzosin Hydrochloride Sustained Release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alfuzosin Hydrochloride Sustained Release Tablets industry.
This Insight Report provides a comprehensive analysis of the global Alfuzosin Hydrochloride Sustained Release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alfuzosin Hydrochloride Sustained Release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alfuzosin Hydrochloride Sustained Release Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alfuzosin Hydrochloride Sustained Release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alfuzosin Hydrochloride Sustained Release Tablets.
United States market for Alfuzosin Hydrochloride Sustained Release Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Alfuzosin Hydrochloride Sustained Release Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Alfuzosin Hydrochloride Sustained Release Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Alfuzosin Hydrochloride Sustained Release Tablets players cover Mylan, Teva, Apotex, Torrent Pharmaceuticals and Sun Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Alfuzosin Hydrochloride Sustained Release Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
2.5mg
5mg
10mg
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mylan
Teva
Apotex
Torrent Pharmaceuticals
Sun Pharma
Aurobindo
Wockhardt
Unichem Laboratories
Sanofi
Lunanbet Pharmaceutical
CSPC Pharmaceutical Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Alfuzosin Hydrochloride Sustained Release Tablets market?
What factors are driving Alfuzosin Hydrochloride Sustained Release Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Alfuzosin Hydrochloride Sustained Release Tablets market opportunities vary by end market size?
How does Alfuzosin Hydrochloride Sustained Release Tablets break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Alfuzosin Hydrochloride Sustained Release Tablets by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Alfuzosin Hydrochloride Sustained Release Tablets by Country/Region, 2019, 2023 & 2030
2.2 Alfuzosin Hydrochloride Sustained Release Tablets Segment by Type
2.2.1 2.5mg
2.2.2 5mg
2.2.3 10mg
2.3 Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type
2.3.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2019-2024)
2.3.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue and Market Share by Type (2019-2024)
2.3.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Type (2019-2024)
2.4 Alfuzosin Hydrochloride Sustained Release Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application
2.5.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Market Share by Application (2019-2024)
2.5.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue and Market Share by Application (2019-2024)
2.5.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Application (2019-2024)
3 Global Alfuzosin Hydrochloride Sustained Release Tablets by Company
3.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Breakdown Data by Company
3.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales by Company (2019-2024)
3.1.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Company (2019-2024)
3.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue by Company (2019-2024)
3.2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Company (2019-2024)
3.2.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Company (2019-2024)
3.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Company
3.4 Key Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Product Location Distribution
3.4.2 Players Alfuzosin Hydrochloride Sustained Release Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Alfuzosin Hydrochloride Sustained Release Tablets by Geographic Region
4.1 World Historic Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Geographic Region (2019-2024)
4.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country/Region (2019-2024)
4.2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales by Country/Region (2019-2024)
4.2.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue by Country/Region (2019-2024)
4.3 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth
4.4 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth
4.5 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth
4.6 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth
5 Americas
5.1 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country
5.1.1 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2019-2024)
5.1.2 Americas Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2019-2024)
5.2 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type
5.3 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region
6.1.1 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region (2019-2024)
6.1.2 APAC Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region (2019-2024)
6.2 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type
6.3 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Alfuzosin Hydrochloride Sustained Release Tablets by Country
7.1.1 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2019-2024)
7.1.2 Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2019-2024)
7.2 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type
7.3 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets by Country
8.1.1 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2019-2024)
8.1.2 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2019-2024)
8.2 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type
8.3 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alfuzosin Hydrochloride Sustained Release Tablets
10.3 Manufacturing Process Analysis of Alfuzosin Hydrochloride Sustained Release Tablets
10.4 Industry Chain Structure of Alfuzosin Hydrochloride Sustained Release Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alfuzosin Hydrochloride Sustained Release Tablets Distributors
11.3 Alfuzosin Hydrochloride Sustained Release Tablets Customer
12 World Forecast Review for Alfuzosin Hydrochloride Sustained Release Tablets by Geographic Region
12.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size Forecast by Region
12.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Forecast by Region (2025-2030)
12.1.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Alfuzosin Hydrochloride Sustained Release Tablets Forecast by Type
12.7 Global Alfuzosin Hydrochloride Sustained Release Tablets Forecast by Application
13 Key Players Analysis
13.1 Mylan
13.1.1 Mylan Company Information
13.1.2 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.1.3 Mylan Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Mylan Main Business Overview
13.1.5 Mylan Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.2.3 Teva Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Apotex
13.3.1 Apotex Company Information
13.3.2 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.3.3 Apotex Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Apotex Main Business Overview
13.3.5 Apotex Latest Developments
13.4 Torrent Pharmaceuticals
13.4.1 Torrent Pharmaceuticals Company Information
13.4.2 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.4.3 Torrent Pharmaceuticals Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Torrent Pharmaceuticals Main Business Overview
13.4.5 Torrent Pharmaceuticals Latest Developments
13.5 Sun Pharma
13.5.1 Sun Pharma Company Information
13.5.2 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.5.3 Sun Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sun Pharma Main Business Overview
13.5.5 Sun Pharma Latest Developments
13.6 Aurobindo
13.6.1 Aurobindo Company Information
13.6.2 Aurobindo Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.6.3 Aurobindo Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Aurobindo Main Business Overview
13.6.5 Aurobindo Latest Developments
13.7 Wockhardt
13.7.1 Wockhardt Company Information
13.7.2 Wockhardt Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.7.3 Wockhardt Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Wockhardt Main Business Overview
13.7.5 Wockhardt Latest Developments
13.8 Unichem Laboratories
13.8.1 Unichem Laboratories Company Information
13.8.2 Unichem Laboratories Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.8.3 Unichem Laboratories Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Unichem Laboratories Main Business Overview
13.8.5 Unichem Laboratories Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.9.3 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
13.10 Lunanbet Pharmaceutical
13.10.1 Lunanbet Pharmaceutical Company Information
13.10.2 Lunanbet Pharmaceutical Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.10.3 Lunanbet Pharmaceutical Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Lunanbet Pharmaceutical Main Business Overview
13.10.5 Lunanbet Pharmaceutical Latest Developments
13.11 CSPC Pharmaceutical Group
13.11.1 CSPC Pharmaceutical Group Company Information
13.11.2 CSPC Pharmaceutical Group Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.11.3 CSPC Pharmaceutical Group Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 CSPC Pharmaceutical Group Main Business Overview
13.11.5 CSPC Pharmaceutical Group Latest Developments
14 Research Findings and Conclusion
*If Applicable.